Top Markets
#1 Siren Siren +34.29%
#2 Wiki Cat Wiki Cat +29.28%
#3 Bitway Bitway +20.25%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.79%
#5 TRIA TRIA +17.08%
#6 PulseChain PulseChain +16.92%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.84%
#8 Velvet Velvet +15.27%
#9 Cysic Cysic +14.22%
#10 The Grays Currency The Grays Currency +14.20%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Rank in Stocks #30681
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Share Price
$0.91968646
Market Cap
$15.91M
Change (1 day)
2.23%
Change (1 year)
-54.41%
Country
KR
Trade Xcell Therapeutics, Inc. (373110)

Category

Healthcare
Stock price history for Xcell Therapeutics, Inc. (373110)
Highest end of day price: $0.93 on 2026-08-01

Lowest end of day price: $5.30 on 2024-07-01
Stock price history of Xcell Therapeutics, Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 5.84%
2025 -59.67%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 50.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.87%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 13.01%
BE